Business Wire

DE-CSC

7.3.2019 15:02:12 CET | Business Wire | Press release

Share
CSC Alerts Companies to Increased DNS Hijacking

CSC joins the U.S. Department of Homeland Security’s Cybersecurity and Infrastructure Security Agency, the UK National Cyber Security Centre, and other leading security organizations—including Cisco® Talos, FireEye® , and Akamai—in alerting corporations and the public to the recent widespread, state-sponsored domain name system (DNS) hijacking attacks. The targets of these recent attacks include government, corporate, telecommunication, and infrastructure entities resulting in website and email redirection to collect sensitive information. We urge companies to stay vigilant and employ security protocols to reduce exposure.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190307005082/en/

DNS attacks can lead to criminals redirecting web traffic away from a legitimate site to a rogue site, putting customers and companies at great risk,” says Mark Flegg, product director for Security Services at CSC. “The recent attacks are complex and vicious, exploiting weaknesses in DNS infrastructure that many companies set up once, then neglect. We strongly advise clients to use the tools and recommendations available to get their digital infrastructure secure.”

In response to DNS hijacking risk and other cyber crime, CSC introduced CSC Security CenterSM in 2018. It’s an online interface powered by advanced proprietary algorithms designed to expose security blind spots across domain names, DNS, and digital certificates that make vital online brand assets susceptible to DNS hijacking, phishing, and distributed denial of service attacks.

“Domain and DNS hijacking are not new security threats, which is why we developed CSC Security Center and are encouraged that hundreds of the world's largest companies are using it to help protect these critical online elements that enable them to operate,” says CSC Digital Brand Services General Manager Mark Calandra. “The sophistication and impact of the recent wave of attacks serves as a wakeup call that effectively managing domain names, DNS, and digital certificates needs to be a critical component for enhancing the security posture of any company with an online presence.”

CSC Security Center proactively identifies business-critical domains, and monitors them continually to ensure they’re protected. This includes checking for registry- and registrar-level locks that prevent unauthorized changes, reviewing user permissions, and verifying that security-focused, enterprise-class DNS hosting and digital certificates are implemented.

“The new CSC Security Center was a welcome surprise,” says Altan Changezi, lead infrastructure architect at Manulife. “It very quickly allows me to see—at a high level—our overall digital asset configuration at CSC. This includes the status of our most vital domains, as well as the number of users with privileged access to our CSC-managed web portals. The tool allows us to make proactive decisions to take control of our assets, as well as secure our accounts.”

The constant identification and monitoring of vital domains alerting companies to security blind spots allows them to take quick action to reduce real-world online threats to their web presence, customer data, and business-critical functions.

“CSC Security Center has shown us where we needed to consolidate providers, update our permissions and security protocols to be consistent with the importance of the website, and much more,” says John Howell, IT operations manager at Football Federation Australia. “The interface is user friendly and alerts us to where we need to keep watch or increase security. I’ve never seen anything like it before, and knowing I can chat with my CSC rep about any of the security blind spots that are revealed—and get protected right away—gives us peace of mind that our data and customers are protected.”

CSC Security Center helps clients reduce exposure to cyber crime by providing them a single view into all risk areas.

About CSC

CSC helps businesses thrive online. We help effectively manage, promote, and secure our clients’ valuable brand assets against the threats of the online world. Leading companies around the world choose us to be their trusted partner, including more than 65% of the Interbrand® 100 Best Global Brands. Leveraging state-of-the-art technology, Digital Brand Services delivers outstanding outcomes through our unique account management structure. With our expert, dedicated team, you’ll have a daily point of contact to ensure your brand has the strength it needs to succeed in the 21st century. We help consolidate and secure, monitor and enforce, then optimize and promote your brands to maximize your digital presence, secure your digital intellectual property, and reduce costs. CSC is the world’s leading provider of digital brand services to companies around the globe. Headquartered in Wilmington, Delaware, CSC also operates from offices throughout the U.S., Canada, Europe, and the Asia-Pacific region. Learn more at cscdigitalbrand.services .

Contact:

Laura Crozier Public Relations Manager, USA (302) 693-5401 x. 65526 laura.crozier@cscglobal.com

Marie Le Maitre Global Marketing Manager, EMEA +44 (0)20 75132324 marie.lemaitre@cscglobal.com

Letitia Thian Marketing Manager, APAC +65 6709 0104 x. 80104 letitia.thian@cscglobal.com

CSC ® News Room

Link:

ClickThru

Social Media:

https://www.facebook.com/CSCSince1899/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye